Growing evidence links brain-MRI enlarged perivascular spaces (EPVS) and multiple sclerosis (MS), but their role remains unclear.
Objective:
This study aimed to investigate the cross-sectional associations of EPVS with several neuroinflammatory and neurodegenerative features in a large multicentric-MS cohort.
Methods:
In total, 207 patients underwent 3T axial-T2-weighted brain-MRI for EPVS assessment (EPVS dichotomized into high/low according to ⩾ 2/< 2 rating categories). MRI biomarkers included brain-predicted age and brain-predicted age difference (brain-PAD), central vein sign (CVS)-positive lesion percentage (CVS%), paramagnetic rim and cortical lesions, T2-lesion load, and brain volumetry. The variable relative importance for EPVS-category prediction was explored using a classification random forest approach.
Results:
High EPVS patients were older (49 vs 44 years, p = 0.003), had ⩾ 1 vascular risk factors (VRFs; p = 0.005), lower CVS% (67% vs 78%, p < 0.001), reduced brain volumes (whole brain: 0.63 vs 0.73, p = 0.01; gray matter: 0.36 vs 0.40; p = 0.002), and older brain-predicted age (58 vs 50 years, p < 0.001). No differences were found for neuroinflammatory markers. After adjusting for age and VFRs (multivariate analyses), the high EPVS category correlated with lower CVS% (odds ratio (OR) = 0.98, 95% confidence interval (CI) = 0.96–0.99; p = 0.02), lower whole brain (OR = 0.01, 95% CI = 0.0003–0.5; p = 0.02), gray matter (OR = 0.0004, 95% CI = 0.0000004–0.4; p = 0.03) volumes, and higher brain-PAD (OR = 1.05, 95% CI = 1.01–1.09; p = 0.02). Random forest identified brain-PAD as the most important predictor of high EPVS.
Conclusion:
EPVS in MS likely reflect microangiopathic disease rather than neuroinflammation, potentially contributing to accelerated neurodegeneration.
IneichenBVOkarSVProulxST, et al. Perivascular spaces and their role in neuroinflammation. Neuron2022; 110(21): 3566–3581.
2.
AdamsHHHilalSSchwingenschuhP, et al. A priori collaboration in population imaging: The Uniform Neuro-Imaging of Virchow-Robin Spaces Enlargement consortium. Alzheimers Dement (Amst)2015; 1(4): 513–520.
3.
DoubalFNMacLullichAMFergusonKJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke2010; 41(3): 450–454.
4.
WardlawJMBenvenisteHNedergaardM, et al. Perivascular spaces in the brain: Anatomy, physiology and pathology. Nat Rev Neurol2020; 16(3): 137–153.
5.
BrownRBenvenisteHBlackSE, et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res2018; 114(11): 1462–1473.
6.
GranbergTMoridiTBrandJS, et al. Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: A systematic review and meta-analysis. J Neurol2020; 267(11): 3199–3212.
7.
GeYLawMHerbertJ, et al. Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol2005; 26(9): 2316–2319.
8.
WuerfelJHaertleMWaicziesH, et al. Perivascular spaces—MRI marker of inflammatory activity in the brain. Brain2008; 131(Pt9): 2332–2340.
9.
KilsdonkIDSteenwijkMDPouwelsPJ, et al. Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration. Mult Scler2015; 21(2): 155–162.
10.
GuissetFLolliVBugliC, et al. The central vein sign in multiple sclerosis patients with vascular comorbidities. Mult Scler2021; 27(7): 1057–1065.
11.
IneichenBVCananauCPlatténM, et al. Dilated Virchow-Robin spaces are a marker for arterial disease in multiple sclerosis. eBioMedicine2023; 92: 104631.
12.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
13.
SatiPGeorgeICSheaCD, et al. FLAIR*: A combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology2012; 265(3): 926–932.
14.
SatiPThomassonDMLiN, et al. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Mult Scler2014; 20(11): 1464–1470.
15.
AbsintaMSatiPFechnerA, et al. Identification of chronic active multiple sclerosis lesions on 3T MRI. AJNR Am J Neuroradiol2018; 39(7): 1233–1238.
16.
FilippiMPreziosaPBanwellBL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines. Brain2019; 142(7): 1858–1875.
17.
ManningARBeckESSchindlerMK, et al. T 1 /T 2 ratio from 3T MRI improves multiple sclerosis cortical lesion contrast. J Neuroimaging2023; 33(3): 434–445.
18.
KoberTGranzieraCRibesD, et al. MP2RAGE multiple sclerosis magnetic resonance imaging at 3 T. Invest Radiol2012; 47(6): 346–352.
19.
PotterGMorrisZWardlawJ. “Enlarged perivascular spaces (EPVS): A visual rating scale and user guide.” Guide prepared by Gillian Potter, Zoe Morris and Prof Joanna Wardlaw. Edinburgh: University of Edinburgh, 2015.
20.
DueringMBiesselsGJBrodtmannA, et al. Neuroimaging standards for research into small vessel disease—advances since 2013. Lancet Neurol2023; 22(7): 602–618.
21.
PotterGMDoubalFNJacksonCA, et al. Enlarged perivascular spaces and cerebral small vessel disease. Int J Stroke2015; 10(3): 376–381.
22.
ColeJHPoudelRPKTsagkrasoulisD, et al. Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker. NeuroImage2017; 163: 115–124.
23.
KaratzoglouASmolaAHornikK, et al. Kernlab—An S4 package for kernel methods in R. J Stat Softw2004; 11(9): 1–20.
24.
SatiPOhJConstableRT, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol2016; 12(12): 714–722.
25.
AbsintaMSatiPMasuzzoF, et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol2019; 76(12): 1474.
26.
GeurtsJJGRoosendaalSDCalabreseM, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology2011; 76(5): 418–424.
27.
MaggiPBulckeCVPedriniE, et al. B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. eBioMedicine2023; 94: 104701.
28.
SchillingSTzourioCDufouilC, et al. Plasma lipids and cerebral small vessel disease. Neurology2014; 83(20): 1844–1852.
29.
KingKSPeshockRMRossettiHC, et al. Effect of normal aging versus hypertension, abnormal body mass index, and diabetes mellitus on white matter hyperintensity volume. Stroke2014; 45(1): 255–257.
30.
EkkerMSBootEMSinghalAB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol2018; 17(9): 790–801.
31.
KooTKLiMY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med2016; 15(2): 155–163.
32.
BechmannIGaleaIPerryVH. What is the blood–brain barrier (not)?Trends Immunol2007; 28(1): 5–11.
33.
CumurciucRGuichardJPReizineD, et al. Dilation of Virchow-Robin spaces in CADASIL. Eur J Neurol2006; 13(2): 187–190.
34.
KolbeSCGarciaLMYuN, et al. Lesion volume in relapsing multiple sclerosis is associated with perivascular space enlargement at the level of the basal ganglia. AJNR Am J Neuroradiol2022; 43(2): 238–244.
35.
WangZChenQChenJ, et al. Risk factors of cerebral small vessel disease: A systematic review and meta-analysis. Medicine (Baltimore)2021; 100(51): e28229.
36.
KappusNWeinstock-GuttmanBHagemeierJ, et al. Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry2016; 87(2):181–187.
37.
GeraldesREsiriMMDeLucaGC, et al. Age-related small vessel disease: A potential contributor to neurodegeneration in multiple sclerosis. Brain Pathol2017; 27(6): 707–722.
38.
PantoniL. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol2010; 9(7): 689–701.
39.
CauncaMRDe Leon-BenedettiALatourL, et al. Neuroimaging of cerebral small vessel disease and age-related cognitive changes. Front Aging Neurosci2019; 11: 145.
40.
FilippiMPreziosaPArnoldDL, et al. Present and future of the diagnostic work-up of multiple sclerosis: The imaging perspective. J Neurol2023; 270(3): 1286–1299.
41.
AbsintaMNairGMonacoMCG, et al. The “central vein sign” in inflammatory demyelination: The role of fibrillar collagen type I. Ann Neurol2019; 85(6): 934–942.
42.
SinneckerTClarkeMAMeierD, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol2019; 76(12): 1446.
43.
Al-LouziOLetchumanVManukyanS, et al. Central vein sign profile of newly developing lesions in multiple sclerosis: A 3-year longitudinal study. Neurol Neuroimmunol Neuroinflamm2022; 9(2): e1120.
44.
CavallariMEgorovaSHealyBC, et al. Evaluating the association between enlarged perivascular spaces and disease worsening in multiple sclerosis. J Neuroimaging2018; 28(3): 273–277.
45.
WardlawJMSmithEEBiesselsGJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol2013; 12(8): 822–838.
46.
GeraldesREsiriMMPereraR, et al. Vascular disease and multiple sclerosis: A post-mortem study exploring their relationships. Brain2020; 143(10): 2998–3012.
47.
WisemanSJBastinMEJardineCL, et al. Cerebral small vessel disease burden is increased in systemic lupus erythematosus. Stroke2016; 47(11): 2722–2728.
48.
AlghanimyAWorkLMHolmesWM. The glymphatic system and multiple sclerosis: An evolving connection. Mult Scler Relat Disord2024; 83: 105456.
49.
FitzgeraldKCDamianAConwayD, et al. Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort. Mult Scler2021; 27(12): 1914–1923.
50.
FrankeKGaserC. Ten years of BrainAGE as a neuroimaging biomarker of brain aging: What insights have we gained?Front Neurol2019; 10: 789.
51.
ColeJHRaffelJFriedeT, et al. Longitudinal assessment of multiple sclerosis with the brain-age paradigm. Ann Neurol2020; 88(1): 93–105.
52.
DenissenSEngemannDADe CockA, et al. Brain age as a surrogate marker for cognitive performance in multiple sclerosis. Eur J Neurol2022; 29(10): 3039–3049.
53.
BrierMRLiZLyM, et al. “Brain age” predicts disability accumulation in multiple sclerosis. Ann Clin Transl Neurol2023; 10(6): 990–1001.
54.
GroeschelSChongWKSurteesR, et al. Virchow-Robin spaces on magnetic resonance images: Normative data, their dilatation, and a review of the literature. Neuroradiology2006; 48(10): 745–754.
55.
OkarSVHuFShinoharaRT, et al. The etiology and evolution of magnetic resonance imaging-visible perivascular spaces: Systematic review and meta-analysis. Front Neurosci2023; 17: 1038011.
56.
SchwartzDLBoespflugELLahnaDL, et al. Autoidentification of perivascular spaces in white matter using clinical field strength T1 and FLAIR MR imaging. NeuroImage2019; 202: 116126.
57.
DubostFYilmazPAdamsH, et al. Enlarged perivascular spaces in brain MRI: Automated quantification in four regions. NeuroImage2019; 185: 534–544.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
